Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Hunt

Showing results (761-770 of 1,059) with videos related to

Pageof 106
Sort By:
Annals of Surgical Oncology|March 22, 2008
Timing of surgical intervention for the intact primary in stage IV breast cancer patientsRoshni Rao, Lei Feng, Henry M Kuerer, et al.
Journal of the American College of Surgeons|October 6, 2009
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United StatesGrace L Smith, Ying Xu, Ya-Chen T Shih, et al.
Annals of Surgical Oncology|September 28, 2011
Triple-negative breast cancer is not a contraindication for breast conservationFarrell C Adkins, Ana Maria Gonzalez-Angulo, Xiudong Lei, et al.
Annals of Surgical Oncology|July 3, 2026
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular CarcinomaGenevieve A Fasano, Jason Mouabbi, Helen M Johnson, et al.
Annals of Surgical Oncology|July 6, 2026
Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?Courtney M Lattimore, Kerollos Nashat Wanis, Henry M Kuerer, et al.
Clinical Breast Cancer|November 5, 2017
Expanding Implementation of ACOSOG Z0011 in Surgeon PracticeAnna Weiss, Elizabeth A Mittendorf, Sarah M DeSnyder, et al.
Transplantation|December 10, 1997
Characterization of pigs transgenic for human decay-accelerating factorE Cozzi, A W Tucker, G A Langford, et al.
Molecular Cancer Research : MCR|September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple CancersKavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Cancer Research|August 15, 2008
Staging of breast cancer in the neoadjuvant settingJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Breast Cancer Research and Treatment|September 14, 2007
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 yearsJiachun Lu, Qingyi Wei, Melissa L Bondy, et al.
Pageof 106

Showing results (761-770 of 1,059) with videos related to

Sort By:
Pageof 106
Annals of Surgical Oncology|March 22, 2008
Timing of surgical intervention for the intact primary in stage IV breast cancer patientsRoshni Rao, Lei Feng, Henry M Kuerer, et al.
Journal of the American College of Surgeons|October 6, 2009
Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United StatesGrace L Smith, Ying Xu, Ya-Chen T Shih, et al.
Annals of Surgical Oncology|September 28, 2011
Triple-negative breast cancer is not a contraindication for breast conservationFarrell C Adkins, Ana Maria Gonzalez-Angulo, Xiudong Lei, et al.
Annals of Surgical Oncology|July 3, 2026
Clinical Impact and Outcomes of Neoadjuvant Systemic Therapy for Invasive Lobular CarcinomaGenevieve A Fasano, Jason Mouabbi, Helen M Johnson, et al.
Annals of Surgical Oncology|July 6, 2026
Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?Courtney M Lattimore, Kerollos Nashat Wanis, Henry M Kuerer, et al.
Clinical Breast Cancer|November 5, 2017
Expanding Implementation of ACOSOG Z0011 in Surgeon PracticeAnna Weiss, Elizabeth A Mittendorf, Sarah M DeSnyder, et al.
Transplantation|December 10, 1997
Characterization of pigs transgenic for human decay-accelerating factorE Cozzi, A W Tucker, G A Langford, et al.
Molecular Cancer Research : MCR|September 28, 2016
AXL Inhibition Suppresses the DNA Damage Response and Sensitizes Cells to PARP Inhibition in Multiple CancersKavitha Balaji, Smruthi Vijayaraghavan, Lixia Diao, et al.
Cancer Research|August 15, 2008
Staging of breast cancer in the neoadjuvant settingJacqueline S Jeruss, Elizabeth A Mittendorf, Susan L Tucker, et al.
Breast Cancer Research and Treatment|September 14, 2007
Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 yearsJiachun Lu, Qingyi Wei, Melissa L Bondy, et al.
Pageof 106